Objective Little data exist regarding long‐term survival in elderly patients with acute myeloid
leukemia (AML). Methods In view of the fact that most deaths occurred during the first 3 yr …

Background. Survival in acute myeloid leukemia (AML) has improved in younger patients
over the last decade. This study was conducted to evaluate the relative survival rates in …

Background In patients over age 60 with acute myeloid leukemia (AML), cure rates are
under 10% despite intensive chemotherapy. These patients often have comorbidities, and …

While the incidence rate of acute myeloid leukaemia (AML) is increasing with the age of the
patients, the 5-year-survival rates are decreasing in an age-dependent manner. Patients …

We retrospectively assessed seventy-four consecutive patients with AML over 65 years of
age (median 71: range 65-88) treated with an individualized approach in two specialized …

The aim of this study was to evaluate the impact of an intensive induction treatment on
overall survival in elderly patients (age≥ 66 years) with acute myeloid leukemia (AML) …

Between 1969 and 1999, 420 patients (age> 60 years) with newly diagnosed AML were
managed at St Bartholomew's Hospital (SBH), London, UK. Sixty-nine percent of patients …

Acute myeloid leukemia (AML) in the elderly is associated with several distinctive biological
and clinical features compared to younger patients. Despite the advances in supportive care …

Dealing with acute myeloid leukemia (AML) in older patients is a twofold challenge. First,
these patients do not show the increasing cure rates seen in younger patients. While their …

More than half of acute myeloid leukemia (AML) diagnoses are currently made in patients
older than 60 years. Furthermore, even if the age-specific incidence remains stable in the …